Picture of Carmat SA logo

ALCAR Carmat SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Carmat Reports 2023 Sales Of €2.8 Million

April 24 (Reuters) - Carmat SA  ALCAR.PA :
    * 2023 SALES OF €2.8 MILLION, I.E. 17 AESON® IMPLANTS,
INCLUDING
11 IN THE LAST QUARTER
    * 12-MONTH FINANCING REQUIREMENTS ESTIMATED AT AROUND €45
MILLION
    * 2024 SALES FORECAST OF AROUND €14 MILLION
    * ACTIVE EXPLORATION OF FINANCING OPTIONS TO EXTEND, IN THE
SHORT-TERM, THE COMPANY'S FINANCIAL HORIZON BEYOND MAY 2024
    * FY NET LOSS EUR 53.9 MILLION VERSUS LOSS OF EUR 53.7
MILLION
YEAR AGO
    * FY NET OPERATING EXPENSES EUR -52.5 MILLION VERSUS EUR
-51.9
MILLION YEAR AGO
    * END-DEC CASH POSITION AT €8.0 MILLION (VERSUS €51.4
MILLION AT
THE END OF 2022)

Source text for Workspace:  ID:nFWN3GX037 
Further company coverage:  ALCAR.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Carmat SA

See all news